cro.directory
← Compare landing

Cisema vs SanaClis

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryCisemaSanaClis
SummaryCisema supports medical device, IVD, pharmaceutical, and cosmetics companies with NMPA-related product registration, China device clinical studies, and local authorized representative services across China and Asia Pacific. Its offerings also include vigilance and post-market surveillance, quality compliance, and reimbursement market access work.Global full-service CRO founded in 2000, offering end-to-end clinical trial support across all phases with integrated clinical supply chain management, logistics, and strategic sourcing capabilities.
Services
  • Clinical Trial Services
  • Clinical Operations
  • Pharmacovigilance & Drug Safety
  • Regulatory Affairs
  • China NMPA Regulatory Strategy
  • Clinical Trial Services
  • Phase I Clinical Trials
  • Phase II Clinical Trials
  • Phase III Clinical Trials
  • Phase IV / Post-Marketing
  • Clinical Operations
  • Pharmacovigilance & Drug Safety
  • Regulatory Affairs
ModalitiesData not yet provided.Data not yet provided.
IndicationsData not yet provided.Data not yet provided.
PhasesData not yet provided.
  • Phase I
  • Phase II
  • Phase III
  • Phase IV
Sourcing modelsData not yet provided.
  • Full-Service Outsourcing (FSO)
  • Functional Service Provider (FSP)
Locations
  • Hong Kong (Headquarters), Hong Kong, Hong Kong
  • Beijing, Beijing, China
  • Tianjin, Tianjin, China
  • Hangzhou, Hangzhou, China
  • Qingdao, Qingdao, China
  • Headquarters
  • Vienna, Vienna, Austria
CertificationsData not yet provided.Data not yet provided.

Find similar companies

Cisema alternatives · SanaClis alternatives

Markdown mirror: /compare/cisema/sanaclis.md